戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  between acetylcholine and nicotine, a known appetite suppressant.
2  inhibitor, has been widely prescribed as an appetite suppressant.
3 rogen-lowering agents that can act as sexual appetite suppressants.
4                   No men reported the use of appetite suppressants.
5 0,000 subjects among those who had not taken appetite suppressants (95 percent confidence interval, 0
6                                          The appetite suppressant aminorex fumarate is thought to hav
7 n epidemic of PPH due to the ingestion of an appetite suppressant, aminorex fumarate.
8       The association between the use of any appetite suppressant and cardiac-valve abnormalities was
9     Phenylpropanolamine is commonly found in appetite suppressants and cough or cold remedies.
10 We also recruited subjects who had not taken appetite suppressants and who were matched to the patien
11 the amphetamine derivatives fenfluramine (an appetite suppressant) and 3,4-methylenedioxymethamphetam
12 e comparison with subjects who had not taken appetite suppressants), and 35.0 per 10,000 subjects amo
13  results suggest that phenylpropanolamine in appetite suppressants, and possibly in cough and cold re
14                    Our results indicate that appetite suppressant-associated PH is identical to PPH n
15 0.02) for the association between the use of appetite suppressants containing phenylpropanolamine and
16 this study was to assess the efficacy of the appetite suppressant d-fenfluramine in the treatment of
17 eeding, thus making NPY receptors attractive appetite suppressant drug targets for treating obesity.
18                                          The appetite-suppressant drug fenfluramine, usually given in
19 neficial metabolic effects of lorcaserin, an appetite-suppressant drug that selectively activates ser
20 common and include those associated with the appetite-suppressant drugs, including phentermine-fenflu
21 ets for advanced classes of antidiabetic and appetite-suppressant drugs.
22                                    The acute appetite suppressant effect of dexfenfluramine (DF) in r
23      It remains unknown if sex modulates the appetite suppressant effect of ketosis.
24 n observed in patients taking the now-banned appetite suppressant fenfluramine (Pondimin, Redux).
25                              Since then, the appetite suppressants fenfluramine and dexfenfluramine,
26 se reports suggest that a combination of the appetite suppressants fenfluramine and phentermine is as
27                                              Appetite suppressants fenfluramine, dexfenfluramine, and
28 y as an adjunct to diet restriction or to an appetite suppressant for the treatment of obesity and re
29  of obesity, which mainly act through CNS as appetite suppressants, have failed during development or
30                                              Appetite suppressants lose efficacy when given chronical
31                                              Appetite suppressants-most commonly fenfluramines-increa
32 alities among the subjects who had not taken appetite suppressants or among those who took only phent
33 reduce body mass principally by acting as an appetite suppressant rather than increasing energy consu
34                   Fortunately, most cases of appetite suppressant-related valve disease are mild or m
35  P=0.03) for the association with the use of appetite suppressants that contained phenylpropanolamine
36 in the United States for long-term use as an appetite suppressant until it was reported to be associa
37 propanolamine, a well-known over-the-counter appetite suppressant, was recently removed from the mark
38 ac-valve abnormalities related to the use of appetite suppressants were published, we undertook a stu
39 oup of 9281 obese subjects who had not taken appetite suppressants who were matched to the treated su